FindTrial
Sign In

A study on the clinical characteristics including severity of pulmonary fibrosis by COVID-19

A study on the clinical characteristics including severity of pulmonary fibrosis by COVID-19

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0006312
Enrollment
100
Registered
2021-07-02
Start date
2021-06-14
Completion date
Unknown
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients aged over 19 who admitted to ICU and needed mechanical ventilation due to COVID-19 infection Patients who were confirmed pneumonia by radiological imaging Patients with severe or critical status based on COVID-19 WHO clinical classification

Exclusion criteria

Exclusion criteria: Patients who were previously diagnosed with interstitial lung disease Patients who had been intubated in other hospitals and refered to study hospital

Design outcomes

Primary

MeasureTime frame
Pulmonary fibrosis—

Countries

Korea, Republic of

Contacts

Public ContactJunghyun Kim

National Medical Center

jhkimd29@gmail.com+82-2-2276-2140

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026